Stearyl amine-modified elastic cerosomes for boosting the anti-cancer activity of albendazole

Funding Sponsor

AlMaarefa University

Second Author's Department

Chemistry Department

Find in your Library

https://doi.org/10.3389/fphar.2025.1595177

All Authors

Rofida Albash Hassan M.E. Azzazy Shaimaa Mosallam Mohammed I.A. Hamed Khaled M. Darwish Maha M. Abdel-Fattah Lama A. Alshabani Einas M. Yousef Heba Mohammed Refat M. Selim Ghadeer El-Fadaly Asmaa Saleh Diana E. Aziz

Document Type

Research Article

Publication Title

Frontiers in Pharmacology

Publication Date

1-1-2025

doi

10.3389/fphar.2025.1595177

Abstract

Background: Albendazole (ALB), originally developed as an anthelmintic agent, has been repurposed for use in cancer therapy. In the present work, ALB was incorporated into stearyl amine (SA)-based elastic cerosomes (EC) to improve its anticancer activity. Methods: Stearyl amine elastic cerosomes containing albendazole (SA-EC-ALB) were formulated using the thin-film hydration method. A D-optimal experimental design was applied via Design-Expert® software (version 7) generating 19 formulations. The independent variables included SAA amount (X1), sonication time (X2), ceramide type (X3), and SAA type (X4), while the dependent variables were entrapment efficiency (EE%; Y1), particle size (PS; Y2), and polydispersity index (PDI; Y3). Results: The optimized SA-EC-ALB formulation, prepared with ceramide III and Pluronic L121 through sonication, achieved an entrapment efficiency (EE%) of 92.03 ± 3.53% and a particle size (PS) of 312.05 ± 9.32 nm. In-silico analysis indicated strong interactions between ALB and the vesicular components in water. Moreover, in-vivo evaluation of SA-EC-ALB antitumor activity, performed using the solid Ehrlich tumor model in adult Swiss albino male mice, demonstrated a significant reduction in tumor volume compared to the control group. Conclusion: Loading ALB into SA-EC could potentially induce its anticancer effects.

Link to Full Text
Find this item online

Share

COinS